Cargando…
Astragaloside IV Targets Macrophages to Alleviate Renal Ischemia-Reperfusion Injury via the Crosstalk between Hif-1α and NF-κB (p65)/Smad7 Pathways
(1) Background: Astragaloside IV (AS-IV) is derived from Astragalus membranous (AM), which is used to treat kidney disease. Macrophages significantly affect the whole process of renal ischemia-reperfusion (I/R). The regulation of macrophage polarization in kidneys by AS-IV was the focus. (2) Methods...
Autores principales: | Tang, Lumin, Zhu, Minyan, Che, Xiajing, Yang, Xiaoqian, Xu, Yao, Ma, Qing, Zhang, Ming, Ni, Zhaohui, Shao, Xinghua, Mou, Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863138/ https://www.ncbi.nlm.nih.gov/pubmed/36675720 http://dx.doi.org/10.3390/jpm13010059 |
Ejemplares similares
-
HIF-1α Signaling Activation by Post-Ischemia Treatment with Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury
por: Si, Jingwen, et al.
Publicado: (2014) -
Antihypertension effect of astragaloside IV during cerebral ischemia reperfusion in rats
por: Shen, Fengyan, et al.
Publicado: (2022) -
Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway
por: Li, Lei, et al.
Publicado: (2023) -
Astragaloside IV alleviates heart failure by modulating Nrf-2
por: Feng, Wenxiao, et al.
Publicado: (2022) -
Research Progress on the Ability of Astragaloside IV to Protect the Brain Against Ischemia-Reperfusion Injury
por: Kang, Xianhui, et al.
Publicado: (2021)